Aim Immunotech Inc. · AMEX:AIM
Equels Thomas K bought 24,000 Aim Immunotech Inc. shares (Form 4)
Traded Sep 17, 2026 · Filed Sep 18, 2026
On Sep 17, 2026, Equels Thomas K (Director, CEO & President) bought 24,000 Aim Immunotech Inc. shares at US$0.21 for US$5,040, leaving 126,822 shares. Filed Sep 18, 2026 (Form 4).
- Bought
- 24,000 shares
- Price
- US$0.21
- Value
- US$5,040
- Holding after
- 126,822 shares
- Trading plan
- No
- Role
- Director, CEO & President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Common Stock | Buy | 24,000 | US$0.21 | 126,822 | Direct |
Source
Related
- Aim Immunotech Inc.
- Equels Thomas K
- Aim Immunotech Inc. shareholders
- Form 4 · Equels Thomas K · Sep 17, 2026
- Form 4 · Equels Thomas K · Sep 16, 2026
- Form 4 · Equels Thomas K · Sep 15, 2026
- Schedule 13G · Mitchell P. Kopin · May 27, 2026
- Schedule 13G · Orca Capital AG · May 12, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Schedule 13D/A · Todd Deutsch · Dec 23, 2024